These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37922316)

  • 1. Sociodemographic characteristics and longitudinal progression of multimorbidity: A multistate modelling analysis of a large primary care records dataset in England.
    Chen S; Marshall T; Jackson C; Cooper J; Crowe F; Nirantharakumar K; Saunders CL; Kirk P; Richardson S; Edwards D; Griffin S; Yau C; Barrett JK
    PLoS Med; 2023 Nov; 20(11):e1004310. PubMed ID: 37922316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors, outcomes and healthcare utilisation in individuals with multimorbidity including heart failure, chronic kidney disease and type 2 diabetes mellitus: a national electronic health record study.
    Pasea L; Dashtban A; Mizani M; Bhuva A; Morris T; Mamza JB; Banerjee A
    Open Heart; 2023 Sep; 10(2):. PubMed ID: 37758654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifestyle factors and their relative contributions to longitudinal progression of cardio-renal-metabolic multimorbidity: a prospective cohort study.
    Zhang N; Liu X; Wang L; Zhang Y; Xiang Y; Cai J; Xu H; Xiao X; Zhao X
    Cardiovasc Diabetol; 2024 Jul; 23(1):265. PubMed ID: 39026309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of multimorbidity on survival of patients diagnosed with heart failure: a retrospective cohort study in Singapore.
    Kaur P; Saxena N; You AX; Wong RCC; Lim CP; Loh SY; George PP
    BMJ Open; 2018 May; 8(5):e021291. PubMed ID: 29780030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eleven-year multimorbidity burden among 637 255 people with and without type 2 diabetes: a population-based study using primary care and linked hospitalisation data.
    Zghebi SS; Steinke DT; Rutter MK; Ashcroft DM
    BMJ Open; 2020 Jul; 10(7):e033866. PubMed ID: 32611677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Socioeconomic inequalities in accumulation of multimorbidity in England from 2019 to 2049: a microsimulation projection study.
    Head A; Birkett M; Fleming K; Kypridemos C; O'Flaherty M
    Lancet Public Health; 2024 Apr; 9(4):e231-e239. PubMed ID: 38553142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving outpatient clinic experience: the future of chronic kidney disease care and associated multimorbidity.
    Al-Chalabi S; Alderson H; Garratt N; Green D; Kalra PA; Ritchie J; Santhirasekaran S; Poulikakos D; Sinha S
    BMJ Open Qual; 2023 Aug; 12(3):. PubMed ID: 37532458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on life expectancy of temporal sequence in a multimorbidity cluster of psychosis, diabetes, and congestive heart failure among 1·7 million individuals in Wales with 20-year follow-up: a retrospective cohort study using linked data.
    Owen RK; Lyons J; Akbari A; Guthrie B; Agrawal U; Alexander DC; Azcoaga-Lorenzo A; Brookes AJ; Denaxas S; Dezateux C; Fagbamigbe AF; Harper G; Kirk PDW; Özyiğit EB; Richardson S; Staniszewska S; McCowan C; Lyons RA; Abrams KR
    Lancet Public Health; 2023 Jul; 8(7):e535-e545. PubMed ID: 37393092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts.
    Chiang JI; Hanlon P; Li TC; Jani BD; Manski-Nankervis JA; Furler J; Lin CC; Yang SY; Nicholl BI; Thuraisingam S; Mair FS
    PLoS Med; 2020 May; 17(5):e1003094. PubMed ID: 32379755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Journey to multimorbidity: longitudinal analysis exploring cardiovascular risk factors and sociodemographic determinants in an urban setting.
    Ashworth M; Durbaba S; Whitney D; Crompton J; Wright M; Dodhia H
    BMJ Open; 2019 Dec; 9(12):e031649. PubMed ID: 31874873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consultation rates in people with type 2 diabetes with and without vascular complications: a retrospective analysis of 141,328 adults in England.
    Abner S; Gillies CL; Shabnam S; Zaccardi F; Seidu S; Davies MJ; Adeyemi T; Khunti K; Webb DR
    Cardiovasc Diabetol; 2022 Jan; 21(1):8. PubMed ID: 35012531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethnic differences in early onset multimorbidity and associations with health service use, long-term prescribing, years of life lost, and mortality: A cross-sectional study using clustering in the UK Clinical Practice Research Datalink.
    Eto F; Samuel M; Henkin R; Mahesh M; Ahmad T; Angdembe A; Hamish McAllister-Williams R; Missier P; J Reynolds N; R Barnes M; Hull S; Finer S; Mathur R
    PLoS Med; 2023 Oct; 20(10):e1004300. PubMed ID: 37889900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of timeframes to define long term conditions and sociodemographic factors on prevalence of multimorbidity using disease code frequency in primary care electronic health records: retrospective study.
    Beaney T; Clarke J; Woodcock T; Majeed A; Barahona M; Aylin P
    BMJ Med; 2024; 3(1):e000474. PubMed ID: 38361663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inequalities in incident and prevalent multimorbidity in England, 2004-19: a population-based, descriptive study.
    Head A; Fleming K; Kypridemos C; Schofield P; Pearson-Stuttard J; O'Flaherty M
    Lancet Healthy Longev; 2021 Aug; 2(8):e489-e497. PubMed ID: 36097998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary care consultation length by deprivation and multimorbidity in England: an observational study using electronic patient records.
    Gopfert A; Deeny SR; Fisher R; Stafford M
    Br J Gen Pract; 2021; 71(704):e185-e192. PubMed ID: 33318089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying the impact of pre-existing conditions on the stage of oesophagogastric cancer at diagnosis: a primary care cohort study using electronic medical records.
    Quiroga M; Shephard EA; Mounce LTA; Carney M; Hamilton WT; Price SJ
    Fam Pract; 2021 Jul; 38(4):425-431. PubMed ID: 33346832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of multimorbidity and their association with health outcomes within Yorkshire, England: baseline results from the Yorkshire Health Study.
    Li J; Green M; Kearns B; Holding E; Smith C; Haywood A; Cooper C; Strong M; Relton C
    BMC Public Health; 2016 Jul; 16():649. PubMed ID: 27464646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterising the burden of chronic kidney disease among people with type 2 diabetes in England: a cohort study using the Clinical Practice Research Datalink.
    Cook S; Schmedt N; Broughton J; Kalra PA; Tomlinson LA; Quint JK
    BMJ Open; 2023 Mar; 13(3):e065927. PubMed ID: 36882249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic Characteristics of Multimorbidity and Sociodemographic Factors Associated With Multimorbidity in a Rapidly Aging Asian Country.
    Low LL; Kwan YH; Ko MSM; Yeam CT; Lee VSY; Tan WB; Thumboo J
    JAMA Netw Open; 2019 Nov; 2(11):e1915245. PubMed ID: 31722030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inequalities in developing multimorbidity over time: A population-based cohort study from an urban, multi-ethnic borough in the United Kingdom.
    Bisquera A; Turner EB; Ledwaba-Chapman L; Dunbar-Rees R; Hafezparast N; Gulliford M; Durbaba S; Soley-Bori M; Fox-Rushby J; Dodhia H; Ashworth M; Wang Y
    Lancet Reg Health Eur; 2022 Jan; 12():100247. PubMed ID: 34901910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.